Sichuan Goldstone Asia Pharmaceutical Inc. (SHE:300434)

SHE:300434 Revenue

Sichuan Goldstone Asia Pharmaceutical had revenue of 331.49M CNY in the quarter ending March 31, 2026, with 13.72% growth. This brings the company's revenue in the last twelve months to 1.08B, up 4.59% year-over-year. In the year 2025, Sichuan Goldstone Asia Pharmaceutical had annual revenue of 1.04B, down -5.80%.

• Revenue (ttm): 1.08B
• Revenue Growth: +4.59%
• P/S Ratio: 3.67
• Revenue / Employee: 601.11K
• Employees: 1,794
• Market Cap: 3.95B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.04B	-63.96M	-5.80%
Dec 31, 2024	1.10B	-106.84M	-8.84%
Dec 31, 2023	1.21B	-33.40M	-2.69%
Jan 1, 2023	1.24B	189.10M	17.95%
Jan 1, 2022	1.05B	276.21M	35.53%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 31, 2026

Data Sources Report a data error